Correlation Between Immuneering Corp and Bolt Biotherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immuneering Corp and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immuneering Corp and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immuneering Corp and Bolt Biotherapeutics, you can compare the effects of market volatilities on Immuneering Corp and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immuneering Corp with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immuneering Corp and Bolt Biotherapeutics.

Diversification Opportunities for Immuneering Corp and Bolt Biotherapeutics

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Immuneering and Bolt is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Immuneering Corp and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and Immuneering Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immuneering Corp are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of Immuneering Corp i.e., Immuneering Corp and Bolt Biotherapeutics go up and down completely randomly.

Pair Corralation between Immuneering Corp and Bolt Biotherapeutics

Given the investment horizon of 90 days Immuneering Corp is expected to generate 2.01 times more return on investment than Bolt Biotherapeutics. However, Immuneering Corp is 2.01 times more volatile than Bolt Biotherapeutics. It trades about 0.0 of its potential returns per unit of risk. Bolt Biotherapeutics is currently generating about -0.21 per unit of risk. If you would invest  214.00  in Immuneering Corp on August 28, 2024 and sell it today you would lose (6.00) from holding Immuneering Corp or give up 2.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Immuneering Corp  vs.  Bolt Biotherapeutics

 Performance 
       Timeline  
Immuneering Corp 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Immuneering Corp are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Immuneering Corp showed solid returns over the last few months and may actually be approaching a breakup point.
Bolt Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bolt Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Immuneering Corp and Bolt Biotherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immuneering Corp and Bolt Biotherapeutics

The main advantage of trading using opposite Immuneering Corp and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immuneering Corp position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.
The idea behind Immuneering Corp and Bolt Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA